Volume | 2,015,856 |
|
|||||
News | - | ||||||
Day High | 0.017 | Low High |
|||||
Day Low | 0.0153 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
RemSleep Holdings Inc (QB) | RMSL | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0165 | 0.0153 | 0.017 | 0.016 | 0.016 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
40 | 2,015,856 | US$ 0.016393 | US$ 33,045 | - | 0.0027 - 0.0208 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:59:38 | 75 | US$ 0.01584 | USD |
RemSleep Holdings Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
29.23M | 1.46B | 1.41B | 204k | -1.78M | -0.00 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
RemSleep (QB) News
Date | Time | Source | News Article |
---|---|---|---|
5/29/2024 | 16:18 | Edgar (US Regulatory) | Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:.. |
5/17/2024 | 16:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
5/15/2024 | 14:23 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
2/14/2024 | 07:10 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
2/13/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
2/02/2024 | 15:58 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
12/18/2023 | 15:38 | Edgar (US Regulatory) | Form 8-K - Current report |
9/22/2023 | 15:26 | Edgar (US Regulatory) | Form 8-K - Current report |
9/08/2023 | 14:02 | Edgar (US Regulatory) | Form 8-K - Current report |
8/18/2023 | 05:10 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
8/14/2023 | 15:12 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
7/14/2023 | 08:58 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RMSL Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0169 | 0.018 | 0.0149 | 0.016794 | 3,652,388 | -0.0009 | -5.33% |
1 Month | 0.011 | 0.02 | 0.01 | 0.015449 | 2,603,536 | 0.005 | 45.45% |
3 Months | 0.0085 | 0.02 | 0.0064 | 0.0130548 | 1,641,346 | 0.0075 | 88.24% |
6 Months | 0.0169 | 0.02 | 0.0027 | 0.0115866 | 2,221,991 | -0.0009 | -5.33% |
1 Year | 0.01305 | 0.0208 | 0.0027 | 0.0131382 | 2,065,204 | 0.00295 | 22.61% |
3 Years | 0.01925 | 0.043 | 0.0027 | 0.0176267 | 7,740,589 | -0.00325 | -16.88% |
5 Years | 0.0455 | 0.064 | 0.0012 | 0.0159394 | 6,959,633 | -0.0295 | -64.84% |
RemSleep (QB) Description
RemSleep Holdings, Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of Sleep Apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make the difference and improve the condition of those suffering from Sleep Apnea. |